Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 8—August 2004

Research

Group G Streptococcal Bacteremia in Jerusalem

Ronit Cohen-Poradosu*, Joseph Jaffe*, David Lavi*, Sigal Grisariu-Greenzaid*, Ran Nir-Paz*, Lea Valinsky†, Mary Dan-Goor†, Colin Block*, Bernard Beall‡, and Allon E. Moses*Comments to Author 
Author affiliations: *Hadassah-Hebrew University Medical Center, Jerusalem, Israel; †Ministry of Health Central Laboratory, Jerusalem, Israel; †Hebrew University-Hadassah Medical School, Jerusalem, Israel; ‡Centers for Disease Control and Prevention, Atlanta, GA, USA

Main Article

Table 1

Summary of clinical characteristic of 94 patients with group G streptococcal bacteremia

Characteristic No. of patients (%)
Age (y)

     <10
3 (3.1)
     10–50
28 (29.8)
     51–75
42 (44.7)
     >75
21 (22.3)
   Median (range)
62 (2–92)
Male
51 (54.2)
Median LOHa in days
10
Underlying disorder

      Diabetes mellitus
33 (35.1)
      Malignancy
33 (35.1)
      Hypertension
18 (19.1)
      No disease
8 (8.5)
Type of infection

      Cellulitis
56 (59.6)
      Primary bacteremia
18 (19.1)
      Soft-tissue infectionb
4 (4.3)
      Bone and joint
4 (4.3)
      Endocarditis
3 (3.1)
      Respiratory
3 (3.1)
      Postpartum
1 (1.1)
      Line sepsis
1 (1.1)
      Unknown
4 (4.3)
Death rate 5 (5.3)

aLOH, length of hospitalization.
bSoft tissue infection, pressure sore attributable to diabetes

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO